Journal

Journal of nuclear medicine technology
ISSN: 1535-5675
Titre abrégé: J Nucl Med Technol
Pays: United States
ID NLM: 0430303

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 14 10 2020
accepted: 09 11 2020
pubmed: 29 12 2020
medline: 19 11 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Assessment of residual activity is critical for quality assurance after

Identifiants

pubmed: 33361184
pii: jnmt.120.258251
doi: 10.2967/jnmt.120.258251
doi:

Substances chimiques

Radiopharmaceuticals 0
Yttrium Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-179

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Yung Hsiang Kao (YH)

Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia yung.kao@mh.org.au.
Medical Imaging Department, Cabrini Hospital, Victoria, Malvern, Australia; and.

Alicia Corlett (A)

Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Katrina Jorna (K)

Medical Imaging Department, Cabrini Hospital, Victoria, Malvern, Australia; and.

Alexander Rhodes (A)

Department of Radiology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Dinesh Sivaratnam (D)

Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Medical Imaging Department, Cabrini Hospital, Victoria, Malvern, Australia; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH